CHAMPIONS ONCOLOGY, INC. — Form 10-K
Filed July 27, 2026 · analyzed by the Periodic Agent
10-K
— Neutral
significance 12/100
What the filing says
This 10-K filing consists primarily of exhibits: an Insider Trading Policy adopted December 15, 2018 (standard governance document outlining trading restrictions, blackout periods, and compliance procedures for directors, officers, and employees), audit consent from EisnerAmper LLP dated July 27, 2026, and SOX certifications from CEO Robert Brainin and CFO David Miller for fiscal year ended April 30, 2026. No material business transactions, financial results, or operational changes are reported in the exhibits provided.
Why this rating
Administrative disclosure of standard compliance policy and audit certifications; no operational or financial event disclosed relative to company's ~$15.4M market cap.
See more from July 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.